1. Home
  2. CKPT
  3. CKPT News

Latest Checkpoint Therapeutics Inc. (CKPT) News on November 22, 2024

Checkpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023)
CKPT

Simply Wall St.

7 days ago

Checkpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023)

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
CKPT

GlobeNewswire

9 days ago

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
CKPT

GlobeNewswire

2 months ago

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
CKPT

GlobeNewswire

3 months ago

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

CKPT

MT Newswires

3 months ago

Checkpoint Therapeutics Unveils Secondary Sale of Securities

What Makes Checkpoint Therapeutics (CKPT) a New Buy Stock
CKPT

Zacks

3 months ago

What Makes Checkpoint Therapeutics (CKPT) a New Buy Stock

Individual investors account for 57% of Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) ownership, while public companies account for 9.8%
CKPT

Simply Wall St.

3 months ago

Individual investors account for 57% of Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) ownership, while public companies account for 9.8%

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
CKPT

GlobeNewswire

3 months ago

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

CKPT

MT Newswires

3 months ago

Checkpoint Therapeutics Shares Rise After Q2 Results

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
CKPT

GlobeNewswire

3 months ago

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

CKPT

MT Newswires

4 months ago

Checkpoint Therapeutics Says FDA Accepted Revised Biologics License Application for Cosibelimab

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
CKPT

GlobeNewswire

4 months ago

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

CKPT

MT Newswires

4 months ago

Checkpoint Therapeutics, GC Cell Collaborate on Cancer Research; Shares Rise

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
CKPT

GlobeNewswire

4 months ago

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

CKPT

MT Newswires

5 months ago

Checkpoint Therapeutics Resubmits Biologics License Application for Cosibelimab, Launches $12 Million Direct Share Offering

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CKPT

GlobeNewswire

5 months ago

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
CKPT

GlobeNewswire

5 months ago

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

CKPT

MT Newswires

5 months ago

Checkpoint Therapeutics Plans to Resubmit Application for Cancer Treatment Candidate

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
CKPT

GlobeNewswire

5 months ago

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

Italian energy company targets Britain for fleet of 20 mini-nukes
CKPT

The Telegraph

5 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
CKPT

Simply Wall St.

5 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
CKPT

Simply Wall St.

5 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
CKPT

Simply Wall St.

5 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
CKPT

Motley Fool

5 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
CKPT

Simply Wall St.

5 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Seoul resumes loudspeaker propaganda against North
CKPT

AFP

5 months ago

Seoul resumes loudspeaker propaganda against North

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
CKPT

Simply Wall St.

5 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
CKPT

GlobeNewswire

6 months ago

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)
CKPT

Simply Wall St.

6 months ago

Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
CKPT

GlobeNewswire

6 months ago

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations
CKPT

Simply Wall St.

8 months ago

Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
CKPT

GlobeNewswire

8 months ago

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
CKPT

GlobeNewswire

8 months ago

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

Lakeland Industries (LAKE) is on the Move, Here's Why the Trend Could be Sustainable
CKPT

Zacks

10 months ago

Lakeland Industries (LAKE) is on the Move, Here's Why the Trend Could be Sustainable

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
CKPT

GlobeNewswire

10 months ago

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

Comstock Inc. to Present at the Battery & Precious Metals Virtual Investor Conference on January 30, 2024
CKPT

GlobeNewswire

10 months ago

Comstock Inc. to Present at the Battery & Precious Metals Virtual Investor Conference on January 30, 2024

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal
CKPT

Zacks

10 months ago

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Red Cat to Participate in the 2024 SHOT Show
CKPT

GlobeNewswire

10 months ago

Red Cat to Participate in the 2024 SHOT Show

Canoo Delivered Electric Vehicles to Kingbee
CKPT

GlobeNewswire

10 months ago

Canoo Delivered Electric Vehicles to Kingbee

UEI Announces QuickSet® Software Expansion for Better Entertainment and Increased Engagement through Personalization
CKPT

Business Wire

10 months ago

UEI Announces QuickSet® Software Expansion for Better Entertainment and Increased Engagement through Personalization

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
CKPT

GlobeNewswire

10 months ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Fazoli’s Entices Fans in 2024 with All-New Stuffed Shell Entrées
CKPT

GlobeNewswire

10 months ago

Fazoli’s Entices Fans in 2024 with All-New Stuffed Shell Entrées

Are Investors Undervaluing First United (FUNC) Right Now?
CKPT

Zacks

a year ago

Are Investors Undervaluing First United (FUNC) Right Now?

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06
CKPT

Simply Wall St.

a year ago

Riverview Bancorp (NASDAQ:RVSB) Has Announced A Dividend Of $0.06

Pathfinder Bancorp, Inc. Declares Dividend
CKPT

GlobeNewswire

a year ago

Pathfinder Bancorp, Inc. Declares Dividend

Red Cat Endorses Passing of the American Security Drone Act
CKPT

GlobeNewswire

a year ago

Red Cat Endorses Passing of the American Security Drone Act

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX
CKPT

Business Wire

a year ago

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX

Carter's (CRI) Continues to Focus on Pricing: Stock to Gain
CKPT

Zacks

a year ago

Carter's (CRI) Continues to Focus on Pricing: Stock to Gain

Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook
CKPT

Simply Wall St.

a year ago

Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook

CKPT

Reuters

a year ago

UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy

CKPT

Reuters

a year ago

US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer
CKPT

GlobeNewswire

a year ago

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

Investing in Perma-Fix Environmental Services (NASDAQ:PESI) five years ago would have delivered you a 228% gain
CKPT

Simply Wall St.

a year ago

Investing in Perma-Fix Environmental Services (NASDAQ:PESI) five years ago would have delivered you a 228% gain

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update
CKPT

GlobeNewswire

a year ago

Red Cat Holdings Reports Financial Results for Fiscal Second Quarter 2024 and Provides Corporate Update

DTF Tax-Free Income 2028 Term Fund Inc. Announces Dividends
CKPT

Business Wire

a year ago

DTF Tax-Free Income 2028 Term Fund Inc. Announces Dividends

Red Cat Holdings Selected by U.S. Army as Finalist for Short Range Reconnaissance Tranche 2 Drone Program
CKPT

GlobeNewswire

a year ago

Red Cat Holdings Selected by U.S. Army as Finalist for Short Range Reconnaissance Tranche 2 Drone Program

Iteris Launches Cutting-Edge Integrated Detection and Connected Vehicle System for Safety Applications
CKPT

Business Wire

a year ago

Iteris Launches Cutting-Edge Integrated Detection and Connected Vehicle System for Safety Applications

Red Cat Holdings to Report Fiscal Second Quarter 2024 Financial Results and Provide Corporate Update on Friday, December 15, 2023
CKPT

GlobeNewswire

a year ago

Red Cat Holdings to Report Fiscal Second Quarter 2024 Financial Results and Provide Corporate Update on Friday, December 15, 2023

Red Cat Holdings, Inc. Announces Closing of $9.2 Million Public Offering
CKPT

GlobeNewswire

a year ago

Red Cat Holdings, Inc. Announces Closing of $9.2 Million Public Offering

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
CKPT

InvestorPlace

a year ago

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
CKPT

GlobeNewswire

a year ago

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023

While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68% gain, private equity firms stood to gain the most
CKPT

Simply Wall St.

a year ago

While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68% gain, private equity firms stood to gain the most

Red Cat Holdings, Inc. Announces Pricing of Public Offering
CKPT

GlobeNewswire

a year ago

Red Cat Holdings, Inc. Announces Pricing of Public Offering

Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance
CKPT

GlobeNewswire

a year ago

Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance

Investors in Superior Group of Companies (NASDAQ:SGC) have unfortunately lost 43% over the last three years
CKPT

Simply Wall St.

a year ago

Investors in Superior Group of Companies (NASDAQ:SGC) have unfortunately lost 43% over the last three years

Valens Semiconductor's New USB3.2 Extension Solution Named as CES 2024 Innovation Awards Honoree
CKPT

PR Newswire

a year ago

Valens Semiconductor's New USB3.2 Extension Solution Named as CES 2024 Innovation Awards Honoree

After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)
CKPT

Zacks

a year ago

After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)

MDB Capital Holdings Reports Third Quarter 2023 Results
CKPT

GlobeNewswire

a year ago

MDB Capital Holdings Reports Third Quarter 2023 Results

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference
CKPT

GlobeNewswire

a year ago

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference

Tortoise Announces Final Results of Tender Offers for its Closed-End Funds
CKPT

ACCESSWIRE

a year ago

Tortoise Announces Final Results of Tender Offers for its Closed-End Funds

Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock
CKPT

Simply Wall St.

a year ago

Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock

CKPT

Thomson Reuters StreetEvents

a year ago

Q3 2023 GlycoMimetics Inc Earnings Call

Network-1 Reports Third Quarter Results
CKPT

ACCESSWIRE

a year ago

Network-1 Reports Third Quarter Results

Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
CKPT

GlobeNewswire

a year ago

Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States

Share on Social Networks: